Surfaxin lucinactant regulatory update

FDA accepted for filing DSCO's NDA for Surfaxin humanized lung surfactant to prevent respiratory distress syndrome (RDS) in premature infants. The PDUFA date is Feb. 13, 2005. DSCO plans to submit an ...